Boston Naming Test: Shortened versions for use in Alzheimer's disease
Wendy J. et al. Mack
Bok Engelsk
| Omfang | 5 s.
|
|---|---|
| Utgave | Kopi
|
| Opplysninger | a Four new 15-item versions of the Boston Naming Test (BNT), a 15-item version usedby the Consortium To Establish a Registry fo Alzheimer's Disease(CERAD), and three 30-item BNT versions were studied in 26 subjects with Alzheimer's disease,(AD), and 26 nondemented, neurologically normal controls. The four 15-item versions were statistically equivalent. On each version, controls performed significantly better than AD subjectys, and scores on each could be extrapolated to a complete 60-item BNT score. The CERAD version also differentiated between AD and control subjects, but it was not equivalent to our four versions and could not be as easily extrapolated to a 60-item score. Even and Odd 30-item BNT versions were confirmed to be equivalent, and we further validated a 30-item Empirical version designed to maximally discriminate between AD and normal subjects. Equivalent 15- or 30-item versions of the BNT will be useful in repeated assessments requiring independent forms of naming task, as well as in situations where administration of the complete BNT is not practical.
|
| Emner |
